Jens Watzlawik - Publications

Affiliations: 
2015- Department of Neuroscience Mayo Clinic Florida 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Kamalaldinezabadi SS, Watzlawik JO, Rosenberry TL, Paravastu AK, Stagg SM. Aggregation dynamics of a 150 kDa Aβ42 oligomer: Insights from cryo electron microscopy and multimodal analysis. Computational and Structural Biotechnology Journal. 23: 4205-4213. PMID 39650331 DOI: 10.1016/j.csbj.2024.11.024  0.343
2024 Kamalaldinezabadi SS, Watzlawik JO, Rosenberry TL, Paravastu AK, Stagg SM. Aggregation Dynamics of a 150 kDa Aβ42 Oligomer: Insights from Cryo Electron Microscopy and Multimodal Analysis. Biorxiv : the Preprint Server For Biology. PMID 39131288 DOI: 10.1101/2024.07.30.605873  0.346
2024 Watzlawik JO, Hou X, Richardson T, Lewicki SL, Siuda J, Wszolek ZK, Cook CN, Petrucelli L, DeTure M, Dickson DW, Antico O, Muqit MMK, Fishman JB, Pirani K, Kumaran R, et al. Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue. Autophagy. 1-16. PMID 38802071 DOI: 10.1080/15548627.2024.2356490  0.352
2023 Watzlawik JO, Fiesel FC, Fiorino G, Bustillos BA, Baninameh Z, Markham BN, Hou X, Hayes CS, Bredenberg JM, Kurchaba NW, Fričová D, Siuda J, Wszolek ZK, Noda S, Sato S, et al. Basal activity of PINK1 and PRKN in cell models and rodent brain. Autophagy. 1-12. PMID 38041584 DOI: 10.1080/15548627.2023.2286414  0.312
2023 Hou X, Heckman MG, Fiesel FC, Koga S, Soto-Beasley AI, Watzlawik JO, Zhao J, Valentino RR, Johnson PW, White LJ, Quicksall ZS, Reddy JS, Bras J, Guerreiro R, Zhao N, et al. Genome-wide association study identifies and variants as mitophagy modifiers in Lewy body disease. Medrxiv : the Preprint Server For Health Sciences. PMID 37905059 DOI: 10.1101/2023.10.16.23297100  0.387
2020 Watzlawik JO, Hou X, Truban D, Ramnarine C, Barodia SK, Gendron TF, Heckman MG, DeTure M, Siuda J, Wszolek ZK, Scherzer CR, Ross OA, Bu G, Dickson DW, Goldberg MS, et al. Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples. Autophagy. 1-16. PMID 33112198 DOI: 10.1080/15548627.2020.1834712  0.371
2020 Hou X, Watzlawik JO, Cook C, Liu CC, Kang SS, Lin WL, DeTure M, Heckman MG, Diehl NN, Al-Shaikh FSH, Walton RL, Ross OA, Melrose HL, Ertekin-Taner N, Bu G, et al. Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33090691 DOI: 10.1002/alz.12198  0.571
2018 Singh Angom R, Wang Y, Wang E, Pal K, Bhattacharya S, Watzlawik JO, Rosenberry TL, Das P, Mukhopadhyay D. VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802003R. PMID 30576228 DOI: 10.1096/Fj.201802003R  0.367
2017 Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, Nguyen T, Malphrus KG, Lincoln S, Carrasquillo MM, Ho C, Chakrabarty P, Strickland S, Murray ME, Swarup V, et al. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29107053 DOI: 10.1016/J.Jalz.2017.09.012  0.476
2017 Allen M, Lincoln SJ, Corda M, Watzlawik JO, Carrasquillo MM, Reddy JS, Burgess JD, Nguyen T, Malphrus K, Petersen RC, Graff-Radford NR, Dickson DW, Ertekin-Taner N. ABCA7 loss-of-function variants, expression, and neurologic disease risk. Neurology. Genetics. 3: e126. PMID 28097223 DOI: 10.1212/Nxg.0000000000000126  0.532
2016 Watzlawik JO, Wootla B, Rodriguez M. Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression. Current Pharmaceutical Design. 22: 1049-59. PMID 26899126 DOI: 10.2174/1381612822666151215095940  0.337
2015 Watzlawik JO, Wootla B, Rodriguez M. Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression. Current Pharmaceutical Design. PMID 26667001  0.335
2013 Wootla B, Watzlawik JO, Denic A, Rodriguez M. The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment. Expert Review of Clinical Immunology. 9: 535-49. PMID 23730884 DOI: 10.1586/Eci.13.37  0.333
2013 Skora L, Fonseca-Ornelas L, Hofele RV, Riedel D, Giller K, Watzlawik J, Schulz-Schaeffer WJ, Urlaub H, Becker S, Zweckstetter M. Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants. The Journal of Biological Chemistry. 288: 2994-3002. PMID 23209282 DOI: 10.1074/jbc.M112.423715  0.313
Show low-probability matches.